A Systematic Evaluation of the Two-Component Systems Network Reveals That ArlRS Is a Key Regulator of Catheter Colonization by
Overview
Affiliations
Two-component systems (TCS) are modular signal transduction pathways that allow cells to adapt to prevailing environmental conditions by modifying cellular physiology. has 16 TCSs to adapt to the diverse microenvironments encountered during its life cycle, including host tissues and implanted medical devices. is particularly prone to cause infections associated to medical devices, whose surfaces coated by serum proteins constitute a particular environment. Identification of the TCSs involved in the adaptation of to colonize and survive on the surface of implanted devices remains largely unexplored. Here, using an catheter infection model and a collection of mutants in each non-essential TCS of , we investigated the requirement of each TCS for colonizing the implanted catheter. Among the 15 mutants in non-essential TCSs, the mutant exhibited the strongest deficiency in the capacity to colonize implanted catheters. Moreover, the mutant was the only one presenting a major deficit in PNAG production, the main exopolysaccharide of the biofilm matrix whose synthesis is mediated by the locus. Regulation of PNAG synthesis by ArlRS occurred through repression of IcaR, a transcriptional repressor of operon expression. Deficiency in catheter colonization was restored when the mutant was complemented with the operon. MgrA, a global transcriptional regulator downstream ArlRS that accounts for a large part of the regulon, was unable to restore PNAG expression and catheter colonization deficiency of the mutant. These findings indicate that ArlRS is the key TCS to biofilm formation on the surface of implanted catheters and that activation of PNAG exopolysaccharide production is, among the many traits controlled by the ArlRS system, a major contributor to catheter colonization.
The two-component system ArlRS is essential for wall teichoic acid glycoswitching in .
Kuijk M, Tusveld E, Lehmann E, van Dalen R, Lasa I, Ingmer H mBio. 2024; 16(1):e0266824.
PMID: 39611840 PMC: 11708061. DOI: 10.1128/mbio.02668-24.
Ma X, Wu Z, Li J, Yang Y Infect Drug Resist. 2024; 17:4037-4053.
PMID: 39309069 PMC: 11416117. DOI: 10.2147/IDR.S485049.
Gong F, Xin S, Liu X, He C, Yu X, Pan L Front Microbiol. 2024; 15:1445630.
PMID: 39224216 PMC: 11367570. DOI: 10.3389/fmicb.2024.1445630.
The Functional Study of Response Regulator ArlR Mutants in Staphylococcus Aureus.
Zhou J, Refat M, Guo Y, Zhang J, Jiao M, He W Appl Biochem Biotechnol. 2024; 196(11):7687-7702.
PMID: 38530540 PMC: 11645427. DOI: 10.1007/s12010-024-04919-1.
Ahator S, Wenzl K, Hegstad K, Lentz C, Johannessen M mSystems. 2024; 9(4):e0013024.
PMID: 38470253 PMC: 11019936. DOI: 10.1128/msystems.00130-24.